TransMedics Group, Inc. Current Liabilities
TransMedics Group, Inc. (TMDX) had Current Liabilities of $98.28 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-04
- 2026-06-30: Liabilities, Current $98.28M.
- 2026-03-31: Liabilities, Current $91.92M.
- 2025-12-31: Liabilities, Current $89.31M.
- 2025-09-30: Liabilities, Current $79.72M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $98.28M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $91.92M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $89.31M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $79.72M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $56.62M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $55.60M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $59.91M 10-K · filed 2026-02-24 |
| 2024-09-30 | $60.05M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $54.33M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $50.22M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $54.93M 10-K · filed 2025-02-27 |
| 2023-09-30 | $49.10M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $32.02M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $28.64M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $23.66M 10-K · filed 2024-02-27 |
| 2022-09-30 | $20.69M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $22.74M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $20.26M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $23.24M 10-K · filed 2023-02-27 |
| 2021-09-30 | $15.92M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $15.08M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $11.76M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $11.88M 10-K · filed 2022-03-01 |
| 2020-09-30 | $13.62M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $13.82M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $15.04M 10-Q · filed 2020-05-06 |
| 2019-12-28 | $16.11M 10-K · filed 2021-03-11 |
| 2019-09-28 | $14.64M 10-Q · filed 2019-11-08 |
| 2019-06-29 | $15.38M 10-Q · filed 2019-08-08 |
| 2019-03-30 | $16.20M 10-Q · filed 2019-06-12 |
| 2018-12-29 | $12.55M 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |